By Alex Wolf ( April 6, 2015, 4:47 PM EDT) -- Wyeth Inc. and Teva Pharmaceuticals USA Inc. on Thursday urged the Third Circuit to transfer an appeal in their pay-for-delay case over the antidepressant Effexor XR to the Federal Circuit, arguing that patent law is essential to the antitrust claims made by the drug purchasers, thereby justifying a transfer....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.